Medicare Insourcing Services

Medicare Insourcing Services 21 April 2026
Medicare Featured

Medicare Logo

Sector: Healthcare
Deal Type: MBO
Location: London
Press Release: Bay Tree Private Equity backs Medicare Insourcing Services


About Medicare

Medicare Insourcing Services Limited (“Medicare”) is a leading provider of clinical insourcing services to the NHS, specialising in practitioner-led diagnostic imaging, primarily ultrasound. The business partners with NHS Trusts to deliver additional capacity within hospital settings, helping reduce waiting lists and improve patient outcomes. Founded in 2018, Medicare has built a strong national footprint, supported by a high-quality network of advanced practitioners and a reputation for consistent clinical delivery.


Investment rationale

Medicare operates in a structurally attractive market, underpinned by persistent NHS capacity constraints, rising diagnostic demand and acute workforce shortages. Its practitioner-led model provides a cost-effective and scalable solution for NHS Trusts, while its established clinician network and strong governance framework create a defensible competitive position. The business benefits from high levels of repeat activity across a diversified base of Trust relationships and an asset-light model with strong cash generation.

“Bay Tree stood out as a partner that really understood both the commercial opportunity and the operational realities of working within the NHS. Their approach was thoughtful and collaborative throughout, and we were particularly impressed by the value that Stephen Collier will bring as Chair as we scale the business.”

Scott Littlefield – CEO


The Bay Tree difference

Bay Tree is working closely with management to support Medicare’s next phase of growth, including expanding its clinician network, deepening NHS Trust relationships and developing adjacent diagnostic services. The firm’s hands-on approach and sector experience are complemented by the appointment of Stephen Collier as Chair, bringing deep NHS and private healthcare expertise. Bay Tree’s flexible investment model and alignment with management position the business strongly to scale and deliver long-term value.


Interested in buying the business you manage or keen to secure growth capital?

CONTACT US

asdasdasdas

Bay Tree Private Equity LLP (FRN 788586, Partnership No. OC418686) is an appointed representative of Suntera Advisers (UK) Limited (FRN 692447), which is authorised and regulated by The Financial Conduct Authority. Suntera Advisers (UK) Limited acts as the Principal Firm to Appointed Representatives. Registered address Bay Tree Private Equity LLP, 85 Great Portland Street, First Floor, London, W1W 7LT (please note this is not an office address).